| pubmed-article:4149697 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0039231 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0032896 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0033497 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:4149697 | lifeskim:mentions | umls-concept:C0076790 | lld:lifeskim |
| pubmed-article:4149697 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:4149697 | pubmed:dateCreated | 1974-4-5 | lld:pubmed |
| pubmed-article:4149697 | pubmed:abstractText | The effects of tolamolol, propranolol and practolol on both isoprenaline- and exercise-induced tachycardia have been studied in conscious dogs. Tolamolol was approximately equipotent to propranolol and 50 times more potent than practolol in antagonizing exercise-induced tachycardias, but was approximately 12 times less potent than propranolol and 8 times more potent than practolol in blocking isoprenaline-induced tachycardia. It is suggested that antagonism of the tachycardia induced by exercise affords a more meaningful assessment of the possible therapeutic potential of beta-adrenoceptor blocking drugs than does that induced by isoprenaline. | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4149697 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4149697 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4149697 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:4149697 | pubmed:issn | 0007-1188 | lld:pubmed |
| pubmed-article:4149697 | pubmed:author | pubmed-author:ScholfieldP... | lld:pubmed |
| pubmed-article:4149697 | pubmed:author | pubmed-author:PullmanL GLG | lld:pubmed |
| pubmed-article:4149697 | pubmed:author | pubmed-author:AdamK RKR | lld:pubmed |
| pubmed-article:4149697 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4149697 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:4149697 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4149697 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4149697 | pubmed:pagination | 560-3 | lld:pubmed |
| pubmed-article:4149697 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:meshHeading | pubmed-meshheading:4149697-... | lld:pubmed |
| pubmed-article:4149697 | pubmed:year | 1973 | lld:pubmed |
| pubmed-article:4149697 | pubmed:articleTitle | Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol. | lld:pubmed |
| pubmed-article:4149697 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:4149697 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4149697 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4149697 | lld:pubmed |
